Taiyo is latest Japanese firm to hike contract manufacturing
10-Mar-2004 - Japan's Taiyo Pharmaceutical Industry is planning to increase its contract manufacturing operations in the wake...
Restructuring eats into profits at leading chemicals group
09-Mar-2004 - A fall in demand from the pharmaceuticals industry has caused a significant hole in 2003...
New contract manufacture for high-potency drugs
04-Mar-2004 - Germany's Haupt Pharma and Wulfing Holding have joined forces to create a new company specialising...
New French player in contract biomanufacturing
01-Mar-2004 - Two France-based companies have pooled their resources to set up a new venture specialising in...
Hexal buys chemical synthesis plant
01-Mar-2004 - Pharmaceuticals manufacturer Hexal has bought a facility near Dresden from specialty chemicals firm Degussa.
Sigma-Aldrich expands in India
27-Feb-2004 - Chemicals company Sigma-Aldrich is to build an $8 million (€6.5m) laboratory-scale production facility for pharmaceuticals...
Boehringer to make prostate cancer antibody
25-Feb-2004 - Boehringer Ingelheim has won a contract to develop a commercial-scale manufacturing process for a new...
Diversa aims at $100m enzyme business
25-Feb-2004 - Diversa has entered into a deal aimed at boosting its manufacturing capacity in enzymes used...
Akzo cuts staff at Diosynth unit
23-Feb-2004 - Dutch chemical company Akzo Nobel followed through on its plans to cut costs at its...
New contracts boost Lonza
23-Feb-2004 - Lonza has signed two new agreements for the supply of monoclonal antibody-based drugs that provide...
Pharma still weak as DSM profits slide
11-Feb-2004 - DSM of the Netherlands saw its operating profit slump 23 per cent to €294 million...
Cobra slumps on profit warning
10-Feb-2004 - Shares in Cobra Biomanufacturing of the UK fell 30 per cent yesterday after the contract...
Sandoz launches into cell culture synthesis
04-Feb-2004 - Novartis' generic drugs subsidiary Sandoz has opened two new manufacturing plants in Austria and Slovenia...
Solutia Europe safe from US woes
04-Feb-2004 - The European arm of international chemicals company Solutia has completed a restructuring of its finances...
Akzo comes in low but above targets in 03
03-Feb-2004 - Pharmaceutical, chemical and coatings company Akzo Nobel reported a 9 per cent slide in net...
Dow swings to profit as revenues surge
30-Jan-2004 - Dow said that increased demand for its products lifted fourth-quarter sales by 20 per cent...
Monsanto strikes back in Solutia dispute
28-Jan-2004 - Monsanto and Pfizer's Pharmacia subsidiary have asked a federal judge to either deny or postpone...
Tetrionics ramps up potent API business
28-Jan-2004 - Active pharmaceutical ingredient manufacturer Tetrionics is planning to double the capacity at a facility in...
Interest relief helps Solutia struggle on
19-Jan-2004 - Chemicals and drug development company Solutia - forced to file for bankruptcy in the US...
Rhodia: no comment on divestment rumours
08-Dec-2003 - Chemicals company Rhodia has played down reports in the French press that it is considering...
New helmsman at Cambrex
20-Nov-2003 - Active pharmaceutical ingredient (API) specialist Cambrex has appointed a new president and chief executive charged...
Aventis seeks time for Rhodia sale
05-Nov-2003 - Franco-German drugmaker Aventis has responded to reports claiming that it is seeking to delay the...
Development services shake-up for Rhodia
29-Oct-2003 - After a difficult period which has seen the departure of its chief executive and first-half...
Rhodia to close US paracetamol plant
27-Aug-2003 - France's Rhodia is to close a production unit for paracetamol/acetaminophen located within the massive Monsanto...
